TD Cowen Maintains Prime Medicine(PRME.US) With Buy Rating

Moomoo NewsFeb 28 10:33 ET · Ratings

TD Cowen Sticks to Its Buy Rating for Prime Medicine, Inc. (PRME)

TipRanksFeb 28 09:37 ET · Ratings

Prime Medicine | 10-K: FY2024 Annual Report

SECFeb 28 08:13 ET · Announcements

Express News | Prime Medicine FY 2024 GAAP EPS $(1.65) Beats $(1.66) Estimate, Sales $2.983M Beats $929.100K Estimate

BenzingaFeb 28 08:05 ET

Prime Medicine Expects Its Cash, Cash Equivalents and Investments as of Dec 31 Will Be Sufficient to Fund Operating Expenses and Cap Expenditure Requirements Into 1H 2026 >PRME

Dow JonesFeb 28 08:02 ET

Prime Medicine FY24 Loss $195.9M >PRME

Dow JonesFeb 28 08:01 ET